Cross-sectional analysis of trace element status in thyroid disease.


Journal

Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS)
ISSN: 1878-3252
Titre abrégé: J Trace Elem Med Biol
Pays: Germany
ID NLM: 9508274

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 31 07 2019
revised: 25 10 2019
accepted: 01 11 2019
pubmed: 14 12 2019
medline: 9 10 2020
entrez: 14 12 2019
Statut: ppublish

Résumé

The synthesis of thyroid hormone depends on a set of trace elements, most importantly selenium and iodine. The dietary supply with certain micronutrients is limited in many areas of the world, including central Europe and large parts of Asia and Africa. Moreover, both thyroid disease risk and therapy effects are modulated by trace element supply and status. Assessment of trace element status in thyroid patients in a European metropolis. Adult patients visiting a medical praxis in Berlin, Germany, were enrolled into a cross-sectional analysis, and serum samples were obtained from thyroid patients (n = 323) with different conditions including goitre, hypothyroidism, malignancy or autoimmune thyroid disease. Trace elements (iodine, selenium, copper and zinc) were assessed by ICP-MS/MS or total reflection X-ray analysis, along with two protein biomarkers of selenium status (selenoprotein P, glutathione peroxidase), and compared to the clinical phenotype. The patients displayed relatively low serum zinc and selenium concentrations as compared to a set (n = 200) of healthy subjects (zinc; 1025+/-233 vs. 1068+/-230 μg/L, p < 0.01, selenium; 76.9+/18.8 vs. 85.1+/-17.4 μg/L, p < 0.0001). A high fraction of patients (37.5%) was classified as selenium-deficient (serum selenium concentrations <70 μg/L), in particular the patients with thyroid malignancy (59%). Serum copper was not different between the groups, and total serum iodine concentrations were unrelated to thyroid disease. Explorative statistical analyses yielded no significant interactions between the trace elements and disease parameters, except for free thyroxine inversely correlating to the copper/selenium ratio. In adult thyroid patients, there is no relation of circulating copper, iodine, selenium or zinc concentrations to thyroid hormone. However, a large fraction of German thyroid patients displays a considerable selenium deficit, known to constitute a disease risk potentially impairing convalescence and aggravating autoimmune disease processes. It appears advisable to testing thyroid patients for selenium deficiency, and once diagnosed, an increased supply via dietary counselling or active supplementation should be considered.

Sections du résumé

BACKGROUND BACKGROUND
The synthesis of thyroid hormone depends on a set of trace elements, most importantly selenium and iodine. The dietary supply with certain micronutrients is limited in many areas of the world, including central Europe and large parts of Asia and Africa. Moreover, both thyroid disease risk and therapy effects are modulated by trace element supply and status.
OBJECTIVE OBJECTIVE
Assessment of trace element status in thyroid patients in a European metropolis.
MATERIAL AND METHODS METHODS
Adult patients visiting a medical praxis in Berlin, Germany, were enrolled into a cross-sectional analysis, and serum samples were obtained from thyroid patients (n = 323) with different conditions including goitre, hypothyroidism, malignancy or autoimmune thyroid disease. Trace elements (iodine, selenium, copper and zinc) were assessed by ICP-MS/MS or total reflection X-ray analysis, along with two protein biomarkers of selenium status (selenoprotein P, glutathione peroxidase), and compared to the clinical phenotype.
RESULTS RESULTS
The patients displayed relatively low serum zinc and selenium concentrations as compared to a set (n = 200) of healthy subjects (zinc; 1025+/-233 vs. 1068+/-230 μg/L, p < 0.01, selenium; 76.9+/18.8 vs. 85.1+/-17.4 μg/L, p < 0.0001). A high fraction of patients (37.5%) was classified as selenium-deficient (serum selenium concentrations <70 μg/L), in particular the patients with thyroid malignancy (59%). Serum copper was not different between the groups, and total serum iodine concentrations were unrelated to thyroid disease. Explorative statistical analyses yielded no significant interactions between the trace elements and disease parameters, except for free thyroxine inversely correlating to the copper/selenium ratio.
CONCLUSIONS CONCLUSIONS
In adult thyroid patients, there is no relation of circulating copper, iodine, selenium or zinc concentrations to thyroid hormone. However, a large fraction of German thyroid patients displays a considerable selenium deficit, known to constitute a disease risk potentially impairing convalescence and aggravating autoimmune disease processes. It appears advisable to testing thyroid patients for selenium deficiency, and once diagnosed, an increased supply via dietary counselling or active supplementation should be considered.

Identifiants

pubmed: 31835129
pii: S0946-672X(19)30505-X
doi: 10.1016/j.jtemb.2019.126430
pii:
doi:

Substances chimiques

Biomarkers 0
Trace Elements 0
Copper 789U1901C5
Selenium H6241UJ22B
Zinc J41CSQ7QDS
Thyroxine Q51BO43MG4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

126430

Informations de copyright

Copyright © 2019 Elsevier GmbH. All rights reserved.

Auteurs

Sebastian Mehl (S)

Institute for Experimental Endocrinology, Charité - Universitätsmedizin Berlin, Berlin, D-13353, Germany.

Qian Sun (Q)

Institute for Experimental Endocrinology, Charité - Universitätsmedizin Berlin, Berlin, D-13353, Germany.

Christian L Görlich (CL)

Institute for Experimental Endocrinology, Charité - Universitätsmedizin Berlin, Berlin, D-13353, Germany.

Julian Hackler (J)

Institute for Experimental Endocrinology, Charité - Universitätsmedizin Berlin, Berlin, D-13353, Germany; DFG-Research Group #2558 TraceAGE, Potsdam, Berlin, Jena, Germany.

Johannes F Kopp (JF)

Institute of Nutritional Science, Department of Food Chemistry, University of Potsdam, Arthur-Scheunert-Allee 114-116, Nuthetal, D-14558, Germany; DFG-Research Group #2558 TraceAGE, Potsdam, Berlin, Jena, Germany.

Kostja Renko (K)

Institute for Experimental Endocrinology, Charité - Universitätsmedizin Berlin, Berlin, D-13353, Germany.

Jens Mittag (J)

Center of Brain, Behavior and Metabolism (CBBM), Universität zu Lübeck, Ratzeburger Allee 160, Lübeck, D-23562, Germany.

Tanja Schwerdtle (T)

Institute of Nutritional Science, Department of Food Chemistry, University of Potsdam, Arthur-Scheunert-Allee 114-116, Nuthetal, D-14558, Germany; DFG-Research Group #2558 TraceAGE, Potsdam, Berlin, Jena, Germany.

Lutz Schomburg (L)

Institute for Experimental Endocrinology, Charité - Universitätsmedizin Berlin, Berlin, D-13353, Germany; DFG-Research Group #2558 TraceAGE, Potsdam, Berlin, Jena, Germany. Electronic address: Lutz.Schomburg@charite.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH